Clovis Oncology (CLVS) Bounces Off Lows, Remains Down 13.8%

October 7, 2016 10:44 AM EDT
Get Alerts CLVS Hot Sheet
Price: $59.57 +1.26%

Rating Summary:
    5 Buy, 8 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 19 | New: 11
Trade CLVS Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Clovis Oncology (NASDAQ: CLVS) is bouncing off earlier lows as analysts at Piper Jaffray defend the name following this morning's data which was sub-par to a competitor's. Shares are up 13.8% after trading down nearly 30% earlier.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, FDA, Trader Talk

Related Entities

Piper Jaffray

Add Your Comment